Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency's top ...

Discover key insights from Roivant Sciences' Q1 2025 earnings call, including brepocitinib DM data milestones, financial strength, and strategic ...

According to the company, the approval of the COVID-19 vaccine Spikevax LP.8.1 is based on manufacturing data as well as ...

Roivant (Nasdaq: ROIV) today reported its financial results for the first quarter ended June 30, 2025, and provided a business update.

President Donald Trump said Monday he’s placing the Washington, D.C., police department under federal control and deploying the National Guard to make the nation’s capital safer. Trump has ...

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...